Clinical study on the effects of different concentrations of atropine eye drops on choroidal parameters in myopic children

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100051379

Enrollment

Unknown

Registered

2021-09-22

Start date

2021-10-01

Completion date

Unknown

Last updated

2022-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

A group:0.5% atropine eye drops

B group:0.01% atropine eye drops

Eligibility

Sex/Gender

All

Age

6 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1.Children aged 6 to 12 years; 2.Equivalent spherical: -0.50D~ -6.00D, astigmatism less than-2.00D; 3.Eyes equivalent spherical difference less than 1.50D; 4.Far and near corrected vision >= 0.8; 5.Intraocular pressure 10~21mmHg.

Exclusion criteria

Exclusion criteria: 1.Suffers from eye disease (amblyopia, strabismus, glaucoma, cataract and retinal disease); 2.Previous myopia interventions such as atropine, feed light meter or orthokeratology lens; 3.Allergy to atropine or cyclopentonate; 4.Severe systemic disease.

Design outcomes

Primary

Measure	Time frame
Choroidal thickness;Axial length;Equivalent spherical degree of myopia;Pupil diameter;Amplitude of accommodation;The thickness of the lens;	—

Countries

China

Contacts

Public ContactFu Aicun

The First Affiliated Hospital of Zhengzhou University

fuaicun2019@qq.com+86 15093272336

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026